News
AstraZeneca's Alexion Pharmaceuticals was sued in Massachusetts federal court on Wednesday for allegedly misusing its patents ...
12h
Independent.ie on MSNPharma companies issue demands to stay in EU ahead of expected US tariffs as Irish economy braces itselfNearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to maintain operations in the EU despite threatened US tariffs on imports, ...
Easy Trip Planners Ltd, Dhani Services Ltd, Mahanagar Gas Ltd and Astrazeneca Pharma India Ltd are among the other losers in the BSE's 'A' group today, 16 April 2025.
Donald Trump has said he is drawing up levies on foreign drugs, suggesting they could be 25 per cent and take effect in the ...
Tariffs on Britain’s pharmaceutical industry could deal a severe blow, potentially costing firms billions of pounds ...
Pharmaceuticals are currently exempt from a baseline 10 per cent tax Mr Trump has placed on goods entering the US, but the US ...
In Q4 2024, AstraZeneca PLC (NASDAQ:AZN) was included in 14 billionaire portfolios with a total of $2.20 billion in combined ...
After several weeks and thousands of votes, TV drug ads from Apellis Pharmaceuticals and AstraZeneca found themselves in the ...
US president is now planning import charge on pharmaceuticals in latest controversial move that could hamper UK economy ...
China announced on Friday that it would raise its levies on imports of U.S. goods to 125%, hitting back at U.S. President ...
AstraZeneca Pharma India has voluntarily surrendered the marketing authorisation for its prostate cancer drug Olaparib (Lynparza) citing commercial reasons.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results